Superiority of Modifiled University of Wiscinsin Solution in the Prolonged Preservation of Isolated Rat Heart

적출 쥐 심장의 장시간 보존에 있어서 University of Wisconsin 수정 용액의 우수성

  • Published : 1993.06.01

Abstract

The paucity of donor hearts for transplantation can be remedied by distant heart procurement. Prolonging donor heart preservation is essential for successful clinical cardiac transplantation. Thirty-two isolated rat hearts were perfused with Krebs-Henseleit buffer solution for 15 minutes, arrested and preserved at 4 oC for 4 hours, and then reperfused for 25 minutes. The following three groups were prepared and hemodynamic changes, creatine kinase-MB isoenzyme levels and ultrastructural changes of the myocardium were analysed before and after cardiac arrest. ; Group I : the heart was arrested with the cardioplegic solution [Plegisol, potassium : 16 mM, sodium : 120 mM] and then stored in a solution with ionic compositions of the extracellular fluid [Hartman, potassium : 4 mM, sodium : 130 mM] ; Group II : the heart was arrested with the cardioplegic solution and stored in a solution with ionic compositions of the intracellular fluid [Modified Euro-Collins, potassium : 108 mM, sodium : 10 mM] ; Group III : the heart was arrested with the cardioplegic solution containing adenosine 20 uM, and then stored in a solution with ionic compositions of the intracellular fluid [Modified University of Wisconsin solution, potassium : 119 mM, sodium: 23 mM]. Left ventricular developed pressure at 20 minutes of the reperfusion was significantly higher in group III [64.3 $\pm$ 3.12 mmHg, p<0.01] and group II [58.3 $\pm$ 1.55 mmHg, p<0.05] as compared with group I [51.4$\pm$ 2.78 mmHg]. The time to induce cardiac arrest after infusion of cardioplegic solution with adenosine 20 uM [5.3 $\pm$ 0.30 second, p<0.005] was significantly shorter than without adenosine [10.6$\pm$ 0.55 second]. Coronary flow at 20 minutes of the reperfusion was augmented significantly in group III [9.6$\pm$ 0.50 ml/min, p<0.05, p<0.05] as compared with group I [8.0 $\pm$ 0.41 ml/min] and group II [8.1$\pm$ 0.51 ml/min]. Percentage recovery of left ventricular developed pressure at 20 minutes of the reperfusion was significantly higher in group III [94.6$\pm$ 2.51 %, p<0.005] as compared with group II and in group II [83.1 $\pm$ 1.22 %, p<0.005] as compared with group I [69.9 $\pm$ 1.73 %], and also percentage recovery of coronary flow at 20 minutes of the reperfusion was significantly higher in group III [82.3 $\pm$ 3.86 %, p<0.05] as compared with group II [71.4 $\pm$ 3.46 %] but there was no significant difference between group I and group II. Measured level of creatine kinase-MB isoenzyme at 15 minutes of the reperfusion was significantly lower in group III [1.23 $\pm$ 0.16 ng/ml, p<0.025] and group II [1.42$\pm$ 0.10 ng/ml, p<0.05] as compared with group I [1.79 0.14 ng/ml]. In the semiquantitative evaluation of the ultrastructural changes of the myocardium, mitochondrial score was lower in group III [0.7 $\pm$ 0.21] than in group I [3.1$\pm$ 0.28] and group II [1.7 $\pm$ 0.19], and also the other structural score was lower in group III [2.7$\pm$ 0.99] than in group I [7.9 $\pm$ 0.89] and group II [5.0 $\pm$ 1.22]. In conclusion, the solution with ionic compositions of the intracellular fluid is appropriate for prolonged cardiac preservation, and it appears to be better preserving method for distant procurement when the donor heart is rapidly arrested with cardioplegic solution containing adenosine 20 uM, and then stored with Modified University of Wisconsin solution.

Keywords

References

  1. South Afr Med J v.41 A human cardiac transplantant : An interim report of a successful operation performed at Groot Shuur Hospital Cape Town Barnard,C.N.
  2. J Heart Transplant v.8 The registry of the international society for heart transplantation : sixth official report Heck,C.F.;Shumway,S.J.;Kaye,M.P.
  3. Ann Thorac Surg v.26 Long-distance transportation of human hearts for transplantation Thomas,F.T.;Szabolce,S.S.;Mammana,R.E.(et al.)
  4. Surgery v.86 Distant heart procurement for transplantation Watson,D.C.;Rertz,B.A.;Baumgartner,A.B.(et al.)
  5. Clin Chem v.36 Quantifying the MB isoenzyme of creatine kinase with the Abott IMx immunoassay analyzer Douglas,R.B.;Robin,C.G.;Kathy,K.E.(et al.)
  6. Thorac Cardiovasc Surg v.79 Ultrastructural and cytochemical correlates of myocardial protection by cardiac hypothermia in man Flameng,W.;Borgers,M.;Daenen,W.;Stalpaert,G.
  7. J Thorac Cardiovasc Surg v.96 Long-term neonatal heart preservation Davtyan,H.G.;Corno,A.F.;Laks,H.;Drinkwater,D.
  8. Hibernation and Hypothermia, Perspectives and Challenges The significance and analysis of membrane function in hibernation Willis,J.S.;Fang,L.S.T.;Foster,R.F.;South,F.E.;Hannon,J.P.;willis,J.R.;Pengelleyu,E.T.;Alpert,N.R.
  9. Ann Surg v.175 Primary cause of unsuccessful liver and heart preservationn : Cold sensitivity of the ATP ase system Martin,D.R.;Scott,D.F.;Downes,G.L.;Belzer,F.O.
  10. Lancet v.2 Kidney preservation for transplantatiion Collins,G.M.;Bravo-Shugarman,M.;Terasaki,P.E.
  11. Lancet v.1 Canine Kidney preservation using a new perfusate Sacks,S.A.;Petritsch,P.H.;Kaufman,J.J.
  12. J Thorac Cardiovasc Surg v.74 Preservatiion of canine heart after warm ischemia (zero to thirty minutes) and one to two days of hypothermic storage Toledo-Pereyra,L.H.;sharp,H.L.;lillehei,R.C.
  13. J Thorac Cardiovasc Surg v.93 Cold storage of the rat heart for transplantation : Two types of solution required for aptimal preservation Kohno,H.;Shiki,K.;Ueno,Y.;Tokunaga,K.
  14. J Thorac Cardiovasc Surg v.104 no.5 The myocardial recovery mode after cold storage for transplatation with Colins solution and cardioplegec solution : A functional and metabolic study in the reaet Toshima,Y.;matsuzaki,K.;Mitani,A.(et al.)
  15. Transplantation v.43 Belzer FO: Successful 72-hour preservation of the canine pancreas Wahlberg,J.A.;Love,R.A.;Landegard,L.;Southard,J.H.
  16. Transplantation v.46 Preservation of the canine liver for 24-48 hours using simple cold storage with UW solution Jamieson,N.V.;Sundberg,R.;Lindell,S.;Claesson,K.;Moen,J.;Vreugdenhil,P.K.;Wight,D.G.D.;Southard,J.H.;Belzer,F.O.
  17. Transplantation v.46 Successful172-hour cold storage of dog kidneys with UW solution Pleog,R.J.;Goossens,D.;McAnulty,J.F.;Southard,J.H.;Belzer,F.O.
  18. Diabetes v.38 no.SUP. Ⅰ Use of UW solution in pancresas transplantation D'Alessandro,M.A.;Stratta,R.J.;Sollinger,H.W.;Kalayoglu,M.;Pirsch,J.D.;Belzer,F.O.
  19. Transplantation v.49 Important Components of the UW solution Southard,J.H.;Gulik,T.M.;Belger,F.O.
  20. Circulation v.82 no.5 Prolonged Cardiac Preservation : Evaluation of the University of Wiscosin Preservation Solution by comparision with the St. Thomas Hospital Cadioplegic Solutions in the Rat. Ledingham,S.M.;Katayama,O.;Yacoub,M.
  21. Ann Thorac Surg v.49 Superior myocardial preservation with modified UW solution after prolonged is chemia in the rat heart Yeh,T.Jr.;Hanan,S.A.;Johnson,D.E.(et al.)
  22. Cire Res v.35 Adenine nucleotide metabolism in the heart Berne,R.M.;Rubio,R.
  23. J Thorac Cardiovasc Surg v.98 Adenesine Cardioplegia, Adenosine versus potassium cardioplegia Schubert,T.;Vetler,H.;Opie,L.H.
  24. J Thorac Cardiovasc Surg v.99 Effectiveness of modified University of Wisconsin solution for heart preservation as assessed in heterortiopec rat heart transplant model Okouchi,Y.;Shimizu,K.;Yamaguchi,A.
  25. Fed Proc v.45 Age and species-related differences in adenine mucleotide degradation during myocardial global ischemia Abd-Elfattah,A.S.;Murphy,C.E.;Slater,D.R.;Goldstein,J.P.;Godwin,C.K.;Wechsler,A.S.
  26. Circulation v.78 Myocardial reperfusion injury:role of myocardial hypoxanthine and xantine in free radical-mediated reperfusion injury Abd-Elfattah,A.S.;Jessen,M.E.;Lekven,J.;Doherty,N.E.;Brunsting,L.A.;Wechsler,A.S.
  27. Cire Res v.35 Structural changes in myocardium during acute ischemia Jenning,S.R.;Ganote,C.